Adaptin Bio (APTN) Change in Account Payables (2023 - 2026)

Adaptin Bio has disclosed Change in Account Payables across 4 years of filings, most recently posting -$140781.0 for Q1 2026.

• Quarterly Change in Account Payables rose 79.54% year-over-year to -$140781.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 810.26% YoY) and the FY2025 annual result came in at $496910.0, down 54.02% from the prior year.
• Change in Account Payables fell to -$140781.0 in Q1 2026, from $174014.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $671507.0 in Q3 2025 and bottomed at -$688124.0 in Q1 2025.
• The 4-year median for Change in Account Payables is $4250.0 (2023), against an average of $111836.4.
• The widest YoY moves for Change in Account Payables: up 10241.25% in 2024, down 1666.07% in 2024.
• Adaptin Bio's Change in Account Payables stood at $4250.0 in 2023, then surged by 10015.27% to $429899.0 in 2024, then slumped by 59.52% to $174014.0 in 2025, then tumbled by 180.9% to -$140781.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$140781.0, $174014.0, and $671507.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.